Nadler Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,350
| Closed | -$203K | – | 130 |
|
|
2024
Q4 | $203K | Sell |
2,350
-375
| -14% | -$32.4K | 0.02% | 125 |
|
|
2024
Q3 | $259K | Hold |
2,725
| – | – | 0.03% | 100 |
|
|
2024
Q2 | $249K | Sell |
2,725
-270
| -9% | -$24.7K | 0.03% | 96 |
|
|
2024
Q1 | $272K | Hold |
2,995
| – | – | 0.03% | 89 |
|
|
2023
Q4 | $244K | Sell |
2,995
-1,340
| -31% | -$109K | 0.03% | 95 |
|
|
2023
Q3 | $346K | Hold |
4,335
| – | – | 0.05% | 72 |
|
|
2023
Q2 | $341K | Sell |
4,335
-40
| -0.9% | -$3.15K | 0.05% | 74 |
|
|
2023
Q1 | $340K | Sell |
4,375
-30
| -0.7% | -$2.33K | 0.05% | 78 |
|
|
2022
Q4 | $342K | Buy |
+4,405
| New | +$342K | 0.06% | 76 |
|